Broken String Biosciences

Broken String Biosciences is a biotech company in Cambridge, United Kingdom, founded in 2020. It has raised $15.0M across 1 round, most recently a $15.0M Series A in September 2023.

Powering the future of gene editing development.

Headquarters
Cambridge
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$15.0M
Last Round
$15.0M Series ASep 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.

About

Broken String Biosciences is a Cambridge, UK-based biotechnology company powering the future of gene editing development through its INDUCE-seq platform. Founded in 2020 at the Wellcome Genome Campus, the company provides the BreakMap platform for genome-wide on- and off-target DNA break analysis, enabling cell and gene therapy developers to generate high-quality safety data earlier and faster. INDUCE-seq supports the full development arc from discovery screening through IND-enabling studies, working across diverse cell types and nuclease systems with a single standardized workflow. In 2026, the company filed an FDA Master File for INDUCE-seq as regulatory expectations for genome-wide off-target analysis intensify, and has expanded commercially into Southeast Asia.

Summary

It lists 11–50 employees. It has raised $15.0M in total across 1 round, most recently a $15.0M Series A round in Sep 2023. Investors include Illumina Ventures, Mérieux Equity Partners and Epidarex Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ASep 2023
$15.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Broken String Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/broken-string-biosciences"><img src="https://indexed.vc/api/badge/company/broken-string-biosciences" alt="Broken String Biosciences on Indexed.vc" width="260" height="76" /></a>